NFKB1 and hepatocellular carcinoma: Our interest in these molecules turned to their ability to interfere with NF-κB activation; we tested the cytotoxicity and inhibition capacity of the NF-κB activation of some OA and UA derivatives in HCC cell lines (HepG2, Hep3B, and HA22T/VGH).